Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-29T01:18:26.424Z Has data issue: false hasContentIssue false
  • English
  • Français

Treatment of Acute Mania

Published online by Cambridge University Press:  07 November 2014

Paul E. Holtzheimer  and
John F. Neumaier
Get access Rights & Permissions [Opens in a new window]

Abstract

Mood stabilizers have evolved considerably over the past decade. Lithium, divalproex, and olanzapine are currently Food and Drug Administration-approved for the treatment of acute mania. A number of new and traditional medications have also been tested and are commonly used in clinical practice. Several strategies for managing treatment-resistant mania have been suggested, but few have been rigorously tested. Emphases on rapid stabilization and fewer side effects have raised the bar for what is expected from mood stabilizers and the successful treatment of mania involves a delicate balance between swiftness, short-term tolerability, and long-term safety.

Type
Review Articles
Information
CNS Spectrums , Volume 8 , Issue 12: Bipolar Mood Disorder: Recent Developments Across the Spectrum , December 2003 , pp. 917 - 928
Copyright
Copyright © Cambridge University Press 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry. 2002;159(suppl 4):1–50.Google Scholar
2.Grunze, H, Kasper, S, Goodwin, G, et al.The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania. World J Biol Psychiatry. 2003;4:5–13.CrossRefGoogle ScholarPubMed
3.Neumaier, JF, Dunner, DL. Lithium use in clinical practice. In: Bittar, E, Bittar, N, eds. Biological Psychiatry. Stamford, Conn: JAI Press; 2000:569–583.Google Scholar
4.Bowden, CL, Brugger, AM, Swann, AC, et al.Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA. 1994;271:918–924.CrossRefGoogle ScholarPubMed
5.Tohen, M, Jacobs, TG, Grundy, SL, et al.Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study Group. Arch Gen Psychiatry. 2000;57:841–849.CrossRefGoogle Scholar
6.Chengappa, KN, Baker, RW, Shao, L, et al.Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar mania. Bipolar Disord. 2003;5:1–5.CrossRefGoogle ScholarPubMed
7.Swann, AC, Bowden, CL, Calabrese, JR, Dilsaver, SC, Morris, DD. Pattern of response to divalproex, lithium, or placebo in four naturalistic subtypes of mania. Neurcpsychopharmacology. 2002;26:530–536.CrossRefGoogle ScholarPubMed
8.Bowden, CL. Predictors of response to divalproex and lithium. J Clin Psychiatry. 1995;56(suppl 3):25–30.Google ScholarPubMed
9.Calabrese, JR, Fatemi, SH, Kujawa, M, Woyshville, MJ. Predictors of response to mood stabilizers. J Clin Psychopharmacol. 1996;16(2 suppl 1):24S–31S.CrossRefGoogle ScholarPubMed
10.Swann, AC, Bowden, CL, Morris, D, et al.Depression during mania. Treatment response to lithium or divalproex. Arch Gen Psychiatry. 1997;54:37–42.CrossRefGoogle ScholarPubMed
11.Oluboka, OJ, Bird, DC, Kutcher, S, Kusumakar, V. A pilot study of loading versus titration of valproate in the treatment of acute mania. Bipolar Disord. 2002;4:341–345.CrossRefGoogle ScholarPubMed
12.McElroy, SL, Keck, PE, Stanton, SP, Tugrul, KC, Bennett, JA, Strakowski, SM. A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. J Clin Psychiatry. 1996;57:142–146.Google ScholarPubMed
13.Hirschfeld, RM, Allen, MH, McEvoy, JP, Keck, PE Jr, Russell, JM. Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients. J Clin Psychiatry. 1999;60:815–818.CrossRefGoogle ScholarPubMed
14.Tohen, M, Sanger, TM, McElroy, SL, et al.Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am J Psychiatry. 1999;156:702–709.CrossRefGoogle ScholarPubMed
15.Tohen, M, Baker, RW, Altshuler, LL, et al.Olanzapine versus divalproex in the treatment of acute mania. Am J Psychiatry. 2002;159:1011–1017.CrossRefGoogle ScholarPubMed
16.Tohen, M, Ketter, TA, Zarate, CA, et al.Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am J Psychiatry. 2003;160:1263–1271.CrossRefGoogle ScholarPubMed
17.Zajecka, JM, Weisler, R, Sachs, G, Swann, AC, Wozniak, P, Sommerville, KW. A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder. J Clin Psychiatry. 2002;63:1148–1155.CrossRefGoogle ScholarPubMed
18.Sernyak, MJ, Leslie, DL, Alarcon, RD, Losonczy, MF, Rosenheck, R. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. Am J Psychiatry. 2002;159:561–566.CrossRefGoogle ScholarPubMed
19.McIntyre, RS, McCann, SM, Kennedy, SH. Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities. Can J Psychiatry. 2001;46:273–281.CrossRefGoogle ScholarPubMed
20.Okuma, T, Inanaga, K, Otsuki, S, et al.Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: a double-blind controlled study. Psychopharmocobgy (Berl). 1979;66:211–217.CrossRefGoogle ScholarPubMed
21.Erfurth, A, Kammerer, C, Grunze, H, Normann, C, Walden, J. An open label study of gabapentin in the treatment of acute mania. J Psychiatr Res. 1998;32:261–264.CrossRefGoogle ScholarPubMed
22.Young, LT, Robb, JC, Hasey, GM, et al.Gabapentin as an adjunctive treatment in bipolar disorder. J Affect Disord. 1999;55:73–77.CrossRefGoogle ScholarPubMed
23.McElroy, SL, Soutullo, CA, Keck, PE Jr, Kmetz, GF. A pilot trial of adjunctive gabapentin in the treatment of bipolar disorder. Ann Clin Psychiatry. 1997;9:99–103.CrossRefGoogle ScholarPubMed
24.Cabras, PL, Hardoy, MJ, Hardoy, MC, Carta, MG. Clinical experience with gabapentin in patients with bipolar or schizoaffective disorder: results of an open-label study. J Clin Psychiatry. 1999;60:245–248.CrossRefGoogle ScholarPubMed
25.Pande, AC, Ctockatt, JG, Janney, CA, Werth, JL, Tsaroucha, G. Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group. Bipolar Disord. 2000;2(3 pt 2):249–255.CrossRefGoogle ScholarPubMed
26.Frye, MA, Ketter, TA, Kimbrell, TA, et al.A placebo-controlled study of lamottigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol. 2000;20:607–614.CrossRefGoogle ScholarPubMed
27.Calabrese, JR, Bowden, CL, Sachs, GS, Ascher, JA, Monaghan, E, Rudd, GD. A double-blind placebo-controlled study of lamottigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry. 1999;60:79–88.CrossRefGoogle ScholarPubMed
28.Bowden, CL, Calabrese, JR, McElroy, SL, et al.The efficacy of lamottigine in rapid cycling and non-rapid cycling patients with bipolar disorder. Biol Psychiatry, 1999;45:953–958.CrossRefGoogle ScholarPubMed
29.Ferrier, IN. Lamotrigine and gabapentin. Alternative in the treatment of bipolar disorder. Neuropsychobiology. 1998;38:192–197.CrossRefGoogle ScholarPubMed
30.Erfurth, A, Grunze, H. New perspectives in the treatment of acute mania: a single case report. Prog Neuropsychopharmacol Biol Psychiatry. 1998;22:1053–1059.CrossRefGoogle Scholar
31.Calabrese, JR, Bowden, CL, McElroy, SL, et al.Spectrum of activity of lamotrigine in treatment-teftactory bipolar disorder. Am J Psychiatry. 1999;156:1019–1023.CrossRefGoogle ScholarPubMed
32.Yatham, LN, Kusumakar, V, Calabrese, JR, Rao, R, Scarrow, G, Kroeker, G. Third generation anticonvulsants in bipolar disorder: a review of efficacy and summary of clinical recommendations. J Clin Psychiatry. 2002;63:275–283.CrossRefGoogle ScholarPubMed
33.Berk, M. Lamotrigine and the treatment of mania in bipolar disorder. Eur Neuropsychopharmacol. 1999;9(suppl 4):S119–S123.CrossRefGoogle ScholarPubMed
34.Ichim, L, Berk, M, Brook, S. Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial. Ann Clin Psychiatry. 2000;12:5–10.CrossRefGoogle Scholar
35.Suppes, TSwann, AC, Dennehy, EB, et al.Texas Medication Algorithm Project: development and feasibility testing of a treatment algorithm for patients with bipolar disorder. J Clin Psychiatry. 2001;62:439–447.CrossRefGoogle ScholarPubMed
36.Emrich, HM, Dose, M, von Zerssen, D. The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders. J Affect Disord. 1985;8:243–250.CrossRefGoogle ScholarPubMed
37.Muller, AA, Stoll, KD. Carbamazepine and oxcarbazepine in the treatment of manic syndromes: studies in Germany. In: Emrich, HM, Okuma, T, Muller, AA, eds. Anticonvulsants in Affective Disorders. Amsterdam, Nethetlands: Excerpta Medica; 1984:134–147.Google Scholar
38.Emrich, HM, Altmann, H, Dose, M, von Zerssen, D. Therapeutic effects of GABA-ergic drugs in affective disorders. A preliminary report. Pharmacol Biochem Behav. 1983;19:369–372.CrossRefGoogle ScholarPubMed
39.Hummel, B, Walden, J, Stampfer, R, et al.Acute antimanic efficacy and safety of oxcarbazepine in an open trial with an on-off-on design. Bipolar Disord. 2002;4:412–417.CrossRefGoogle Scholar
40.Nasr, S. Oxcarbazepine for mood disorders. Am J Psychiatry. 2002;159:1793.CrossRefGoogle ScholarPubMed
41.Nassir Ghaemi, S, Ko, JY, Katzow, JJ. Oxcatbazepine treatment of refractory bipolar disorder: a retrospective chart review. Bipolar Disord. 2002;4:70–74.CrossRefGoogle Scholar
42.Bozikas, VP, Petrikis, P, Kourtis, A, Youlis, P, Karavatos, A. Treatment of acute mania with topitamate in hospitalized patients. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26:1203–1206.CrossRefGoogle Scholar
43.Calabrese, JR, Keck, PE Jr, McElroy, SL, Shelton, MD. A pilot study of topiramate as monotherapy in the treatment of acute mania. J Clin Psychopharmacol. 2001;21:340–342.CrossRefGoogle ScholarPubMed
44.Chengappa, KN, Rathore, D, Levine, J, et al.Topiramate as add-on treatment fot patients with bipolar mania. Bipolar Disord. 1999;1:42–53.CrossRefGoogle Scholar
45.Ghaemi, SN, Manwani, SG, Katzow, JJ, Ko, JY, Goodwin, FK. Topiramate treatment of bipolar spectrum disorders: a retrospective chart review. Ann Clin Psychiatry. 2001;13:185–189.CrossRefGoogle ScholarPubMed
46.Grunze, HC, Normann, C, Langosch, J, et al.Antimanic efficacy of topitamate in 11 patients in an open trial with an on-off-on design. J Clin Psychiatry. 2001;62:464–468.CrossRefGoogle Scholar
47.Marcotte, D. Use of topitamate, a new anti-epileptic as a mood stabilizer. J Affect Disord. 1998;50:245–251.CrossRefGoogle Scholar
48.McElroy, SL, Suppes, T, Keck, PE, et al.Open-label adjunctive topiramate in the treatment of bipolar disorders. Biol Psychiatry. 2000;47:1025–1033.CrossRefGoogle ScholarPubMed
49.Normann, C, Langosch, J, Schaerer, LO, Grunze, H, Walden, J. Treatment of acute mania with topitamate. Am J Psychiatry. 1999;156:2014.CrossRefGoogle Scholar
50.Pecuch, PW, Erfurth, A. Topiramate in the treatment of acute mania. J Clin Psychopharmacol. 2001;21:243–244.CrossRefGoogle ScholarPubMed
51.Vieta, E, Torrent, C, Garcia-Ribas, G, et al.Use of topiramate in treatment-tesistant bipolar spectrum disorders. J Clin Psychopharmacol. 2002;22:431–435.CrossRefGoogle ScholarPubMed
52.Chengappa, KN, Gershon, S, Levine, J. The evolving role of topiramate among othet mood stabilizers in the management of bipolar disorder. Bipolar Disord. 2001;3:215–232.CrossRefGoogle Scholar
53.Kaufman, KR. Adjunctive tiagabine treatment of psychiatric disorders: three cases. Ann Clin Psychiatry. 1998;10:181–184.CrossRefGoogle ScholarPubMed
54.Schaffer, LC, Schaffer, CB. Tiagabine and the treatment of refractory bipolar disorder. Am J Psychiatry. 1999;156:2014–2015.CrossRefGoogle ScholarPubMed
55.Grunze, H, Erfurth, A, Marcuse, A, Amann, B, Normann, C, Walden, J. Tiagabine appears not to be efficacious in the treatment of acute mania. J Clin Psychiatry. 1999;60:759–762.CrossRefGoogle Scholar
56.Schaffer, LC, Schaffer, CB, Howe, J. An open case series on the utility of tiagabine as an augmentation in refractory bipolar outpatients. J Affect Disord. 2002;71:259–263.CrossRefGoogle ScholarPubMed
57.Suppes, T, Chisholm, KA, Dhavale, D, et al.Tiagabine in treatment refractory bipolar disorder: a clinical case series. Bipolar Disord. 2002;4:283–289.CrossRefGoogle ScholarPubMed
58.Berigan, TR. Zonisamide treatment of bipolar disorder: a case report. Can J Psychiatry. 2O02;47:887.CrossRefGoogle Scholar
59.Kanba, S, Yagi, G, Kamijima, K, et al.The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania. Prog Neuropsychopharmacol Biol Psychiatry. 1994;18:707–715.Google ScholarPubMed
60.Charles, CL, Stoesz, L, Tollefson, G. Zonisamide-induced mania. Psychosomatics. 1990;31:214–217.CrossRefGoogle ScholarPubMed
61.Lamberty, Y, Margineanu, DG, Klitgaard, H. Effect of the new antiepileptic drug levetitacetam in an animal model of mania. Epilepsy Behav. 2001;2:454–459.CrossRefGoogle Scholar
62.Goldberg, JF, Burdick, KE. Levetiracetam for acute mania. Am J Psychiatry. 2002;159:148.CrossRefGoogle ScholarPubMed
63.Braunig, P, Kruger, S. Levetiracetam in the treatment of rapid cycling bipolar disorder. J Psychopharmacol. 2003;17:239–241.CrossRefGoogle ScholarPubMed
64.Grunze, H, Langosch, J, Born, C, Schaub, G, Walden, J. Levetiracetam in the treatment of acute mania: an open add-on study with an on-off-on design. J Clin Psychiatry. 2003;64:781–784.CrossRefGoogle ScholarPubMed
65.Kalinowsky, LB, Putnam, TJ. Attempts at treatment of schizophrenia and othet non-epileptic psychoses with Dilantin. Arch Neurol Psychiatry. 1943;49:414–420.CrossRefGoogle Scholar
66.Mishory, A, Yaroslavsky, Y, Bersudsky, Y, Belmaker, RH. Phenytoin as an antimanic anticonvulsant: a controlled study. Am J Psychiatry. 2000;157:463–465.CrossRefGoogle ScholarPubMed
67.Yatham, LN, Grossman, F, Augustyns, I, Vieta, E, Ravindran, A. Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial. Br J Psychiatry. 2003;182:141–147.CrossRefGoogle ScholarPubMed
68.Vieta, E, Herraiz, M, Parramon, G, Goikolea, JM, Fernandez, A, Benabarre, A. Risperidone in the treatment of mania: efficacy and safety results from a large, multicentre, open study in Spain. J Affect Disord. 2002;72:15–19.CrossRefGoogle ScholarPubMed
69.Vieta, E, Goikolea, JM, Corbella, B, et al.Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study. J Clin Psychiatry. 2001;62:818–825.CrossRefGoogle ScholarPubMed
70.Vieta, E, Gasto, C, Colom, F, et al.Role of risperidone in bipolar II: an open 6-month study. J Affect Disord. 2001;67:213–219.CrossRefGoogle Scholar
71.Tohen, M, Zarate, CA Jr, Centorrino, F, Hegarty, JI, Froeschl, M, Zarate, SB. Risperidone in the treatment of mania. J Clin Psychiatry. 1996;57:249–253.Google ScholarPubMed
72.Benabarre, A, Vieta, E, Colom, F, Martinez, A, Reinates, M, Corbella, B. Treatment of mixed mania with risperidone and mood stabilizers. Can J Psychiatry. 2001;46:866–867.CrossRefGoogle ScholarPubMed
73.Ghaemi, SN, Sachs, GS, Baldassano, CF, Truman, CJ. Acute treatment of bipolar disorder with adjunctive risperidone in outpatients. Can J Psychiatry. 1997;42:196–199.CrossRefGoogle ScholarPubMed
74.Goodnick, PJ. Risperidone treatment of refractory acute mania. J Clin Psychiatry. 1995;56:431–432.Google ScholarPubMed
75.Guille, C, Sachs, GS, Ghaemi, SN. A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder. J Clin Psychiatry. 2000;61:638–642.CrossRefGoogle ScholarPubMed
76.Lane, HY, Chiu, WC, Chang, WH. Risperidone monotherapy fot mania and depression. Am J Psychiatry. 1999;156:1115.CrossRefGoogle Scholar
77.Licht, RW, Bysted, M, Christensen, H. Fixed-dosed risperidone in mania: an open experimental trial. Int Clin Psychopharmacol. 2001;16:103–110.CrossRefGoogle ScholarPubMed
78.Sachs, GS, Grossman, F, Ghaemi, SN, Okamoto, A, Bowden, CL. Combination of a mood stabilize! with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry. 2002;159:1146–1154.CrossRefGoogle ScholarPubMed
79.Yatham, LN, Binder, C, Riccatdelli, R, Leblanc, J, Connolly, M, Kusumakar, V. Risperidone in acute and continuation treatment of mania. Int Clin Psychopharmacol. 2003;18:227–235.CrossRefGoogle ScholarPubMed
80.Sajatovic, M, DiGiovanni, SK, Bastani, B, Hattab, H, Ramirez, LF. Risperidone therapy in treatment refractory acute bipolar and schizoaffective mania. Psychopharmacol Bull. 1996;32:55–61.Google ScholarPubMed
81.Aubry, JM, Simon, AE, Bertschy, G. Possible induction of mania and hypomania by olanzapine or risperidone: a critical review of reported cases. J Clin Psychiatry. 2000;61:649–655.CrossRefGoogle ScholarPubMed
82.Barkin, JS, Pais, VM Jr, Gaffney, MF. Induction of mania by risperidone resistant to mood stabilizers. J Clin Psychopharmacol. 1997;17:57–58.Google ScholarPubMed
83.Diaz, SF. Mania associated with risperidone use. J Clin Psychiatry. 1996;57:41–42.Google ScholarPubMed
84.Guzelcan, Y, de Haan, L, Scholte, WF. Risperidone may induce mania. Psychopharmacohgy (Berl). 2002;162:85–86.CrossRefGoogle ScholarPubMed
85.Koek, RJ, Kessler, CC. Probable induction of mania by risperidone. J Clin Psychiatry. 1996;57:174–175.Google ScholarPubMed
86.Lane, HY, Lin, YC, Chang, WH. Mania induced by risperidone: dose related? J Clin Psychiatry. 1998;59:85–86.CrossRefGoogle ScholarPubMed
87.O'Croinin, F, Zibin, T, Holt, L. Re: Hypomania associated with risperidone. Can J Psychiatry. 1995;40:51.Google ScholarPubMed
88.Schnierow, BJ, Graeber, DA. Manic symptoms associated with initiation of risperidone. Am J Psychiatry. 1996;153:1235–1236.Google ScholarPubMed
89.Tomlinson, WC. Respiridone and mania. Am J Psychiatry. 1996;153:132–133.Google ScholarPubMed
90.Zolezzi, M, Badr, MG. Risperidone-induced mania. Ann Pharmacother. 1999;33:380–381.CrossRefGoogle ScholarPubMed
91.Yatham, LN. The role of novel antipsychotics in bipolar disorders. J Clin Psychiatry. 2002;63(suppl 3):10–14.Google ScholarPubMed
92.Ghaemi, SN, Katzow, JJ. The use of quetiapine fot treatment-resistant bipolar disorder: a case series. Ann Clin Psychiatry. 1999;11:137–140.CrossRefGoogle Scholar
93.Sajatovic, M, Brescan, DW, Perez, DE, et al.Quetiapine alone and added to a mood stabilizer for serious mood disorders. J Clin Psychiatry. 2001;62:728–732.CrossRefGoogle ScholarPubMed
94.Vieta, E, Parramon, G, Padrell, E, et al.Quetiapine in the treatment of rapid cycling bipolar disorder. Bipolar Disord. 2002;4:335–340.CrossRefGoogle ScholarPubMed
95.Zarate, CA Jr, Rothschild, A, Fletcher, KE, Madrid, A, Zapatel, J. Clinical ptedictors of acute response with quetiapine in psychotic mood disorders. J Clin Psychiatry. 2000;61:185–189.CrossRefGoogle ScholarPubMed
96.Adityanjee, Schulz SC. Clinical use of quetiapine in disease states other than schizophrenia. J Clin Psychiatry. 2002;63(suppl 13):32–38.Google ScholarPubMed
97.Brown, ES, Nejtek, VA, Perantie, DC, Bobadilla, L. Quetiapine in bipolar disorder and cocaine dependence. Bipolar Disord. 2002;4:406–411.CrossRefGoogle ScholarPubMed
98.Dunayevich, E, Strakowski, SM. Quetiapine fot treatment-resistant mania. Am J Psychiatry. 2000;157:1341.CrossRefGoogle Scholar
99.Schallet, JL, Behar, D. Quetiapine fot tefractory mania in a child. J Am Acad Child Adolesc Psychiatry. 1999;38:498–499.CrossRefGoogle Scholar
100.Delbello, MP, Schwiers, ML, Rosenberg, HL, Strakowski, SM. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry. 2002;41:1216–1223.CrossRefGoogle ScholarPubMed
101.Keck, PE Jr, Versiani, M, Potkin, S, West, SA, Giller, E, Ice, K. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Am J Psychiatry. 2003;160:741–748.CrossRefGoogle Scholar
102.Davis, R, Risch, SC. Ziptasidone induction of hypomania in depression? Am J Psychiatry. 2002;159:673–674.CrossRefGoogle ScholarPubMed
103.Lu, BY, Lundgren, R, Escalona, PR, Roberts, BB. A case of ziprasidone-induced mania and the role of 5-HT2A in mood changes induced by atypical antipsychotics. J Clin Psychiatry. 2002;63:1185–1186.CrossRefGoogle ScholarPubMed
104.Taylot, DM. Aripiprazole: a review of its pharmacology and clinical use. Int J Clin Pract. 2003;57:49–54.Google Scholar
105.Antonacci, DJ, Swartz, CM. Clozapine treatment of euphoric mania. Ann Clin Psychiatry. 1995;7:203–206.CrossRefGoogle ScholarPubMed
106.Barbini, B, Scherillo, P, Benedetti, F, Crespi, G, Colombo, C, Smeraldi, E. Response to clozapine in acute mania is more rapid than that of chlorpromazine. Int Clin Psychopharmacol. 1997;12:109–112.CrossRefGoogle ScholarPubMed
107.Calabrese, JR, Kimmel, SE, Woyshville, MJ, et al.Clozapine fot treatment-refractory mania. Am J Psychiatry. 1996;153:759–764.Google Scholar
108.Chanpattana, W. Combined ECT and clozapine in treatment-tesistant mania. J ECT. 2000;16:204–207.CrossRefGoogle ScholarPubMed
109.Green, AI, Tohen, M, Patel, JK, et al.Clozapine in the treatment of refractory psychotic mania. Am J Psychiatry. 2000;157:982–986.CrossRefGoogle ScholarPubMed
110.Mahendran, R. Clozapine in the treatment of hypomania with neurosyphilis. J Clin Psychiatry. 2001;62:477–478.CrossRefGoogle ScholarPubMed
111.Suppes, T, McElroy, SL, Gilbert, J, Dessain, EC, Cole, JO. Clozapine in the treatment of dysphoric mania. Biol Psychiatry. 1992;32:270–280.CrossRefGoogle ScholarPubMed
112.Masi, G, Mucci, M, Millepiedi, S. Clozapine in adolescent inpatients with acute mania. J Child Adolesc Psychopharmacol. 2002;12:93–99.CrossRefGoogle ScholarPubMed
113.Hollister, LE, Trevino, ES. Calcium channel blockers in psychiatric disorders: a review of the literature. Can J Psychiatry. 1999;44:658–664.CrossRefGoogle ScholarPubMed
114.Levy, NA, Janicak, PG. Calcium channel antagonists fot the treatment of bipolar disorder. Bipolar Disord. 2000;2:108–119.CrossRefGoogle Scholar
115.Janicak, PG, Sharma, RP, Pandey, G, Davis, JM. Verapamil for the treatment of acute mania: a double-blind, placebo-controlled trial. Am J Psychiatry. 1998;155:972–973.CrossRefGoogle Scholar
116.Walton, SA, Berk, M, Brook, S. Superiority of lithium ovet vera-pamil in mania: a randomized, controlled, single-blind trial. J Clin Psychiatry. 1996;57:543–546.CrossRefGoogle Scholar
117.Wisner, KL, Peindl, KS, Perel, JM, Hanusa, BH, Piontek, CM, Baab, S. Verapamil treatment for women with bipolar disorder. Biol Psychiatry. 2002;51:745–752.CrossRefGoogle ScholarPubMed
118.Stoll, AL, Severus, WE, Freeman, MP, et al.Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry. 1999;56:407–412.CrossRefGoogle ScholarPubMed
119.Bebchuk, JM, Arfken, CL, Dolan-Manji, S, Murphy, J, Hasanat, K, Manji, HK. A preliminary investigation of a protein kinase C inhibitor in the treatment of acute mania. Arch Gen Psychiatry. 2000;57:95–97.CrossRefGoogle ScholarPubMed
120.Avery, D. Transcranial magnetic stimulation in the treatment of depression. Essent Psychopharmacol. 2001;4:37–48.Google Scholar
121.Holtzheimer, P, Russo, J, Avery, D. A meta-analysis of repetitive transcranial magnetic stimulation in the treatment of depression. Psychopharmacol Bull. 2001;35:149–169.Google ScholarPubMed
122.George, MS, Lisanby, SH, Sackeim, HA. Transcranial magnetic stimulation: applications in neuropsychiatry. Arch Gen Psychiatry. 1999;56:300–311.CrossRefGoogle ScholarPubMed
123.Burt, T, Lisanby, SH, Sackeim, HA. Neutopsychiattic applications of transcranial magnetic stimulation: a meta-analysis. Int J Neuropsychopharmacol. 2002;5:73–103.CrossRefGoogle ScholarPubMed
124.Kozel, FA, George, MS. Meta-analysis of left prefrontal repetitive transcranial magnetic stimulation (rTMS) to treat depression. Journal of Psychiatric Practice. 2002;8:270–275.CrossRefGoogle ScholarPubMed
125.Martin, JL, Barbanoj, MJ, Schlaepfer, TE, et al.Transcranial magnetic stimulation for treating depression. Cochrane Database Syst Rev. 2002(2):CD003493.Google Scholar
126.Menkes, DL, Bodnar, P, Ballesteros, RA, Swenson, MR. Right frontal lobe slow frequency repetitive transcranial magnetic stimulation (SF r-TMS) is an effective treatment for depression: a case-control pilot study of safety and efficacy. J Neurol Neurosurg Psychiatry. 1999;67:113–115.CrossRefGoogle ScholarPubMed
127.Klein, E, Kreinin, I, Chistyakov, A, et al.Therapeutic efficacy of right prefrontal slow repetitive ttansctanial magnetic stimulation in major depression: a double-blind controlled study. Arch Gen Psychiatry. 1999;56:315–320.CrossRefGoogle ScholarPubMed
128.Belmaker, RH, Grisaru, N. Antibipolar potential for ttansctanial magnetic stimulation. Bipolar Disord. 1999;1:71–72.CrossRefGoogle ScholarPubMed
129.Nahas, Z, Molloy, MA, Hughes, PL, et al.Repetitive transcranial magnetic stimulation: perspectives for application in the treatment of bipolar and unipolar disorders. Bipolar Disord. 1999;1:73–80.CrossRefGoogle ScholarPubMed
130.Post, RM, Frye, MA, Denicoff, KD, Leverich, GS, Kimbrell, TA, Dunn, RT. Beyond lithium in the treatment of bipolar illness. Neuropsychopharmacology. 1998;19:206–219.CrossRefGoogle ScholarPubMed
131.Grisaru, N, Chudakov, B, Yaroslavsky, Y, Belmaker, RH. Transcranial magnetic stimulation in mania: a controlled study. Am J Psychiatry. 1998;155:1608–1610.CrossRefGoogle Scholar
132.Erfurth, A, Michael, N, Mostert, C, Arolt, V. Euphoric mania and rapid transcranial magnetic stimulation. Am J Psychiatry. 2000;157:835–836.CrossRefGoogle ScholarPubMed
133.Kaptsan, A, Yaroslavsky, Y, Applebaum, J, Belmaker, RH, Grisaru, N. Right prefrontal TMS versus sham treatment of mania: a controlled study. Bipolar Disord. 2003;5:36–39.CrossRefGoogle Scholar
134.Nedjat, S, Folkerts, HW. Induction of a reversible state of hypomania by rapid-rate transcranial magnetic stimulation over the left prefrontal lobe. J ECT. 1999;15:166–168.CrossRefGoogle ScholarPubMed
135.Garcia-Toro, M. Acute manic symptomatology during repetitive transcranial magnetic stimulation in a patient with bipolar depression. Br J Psychiatry. 1999;175:491.CrossRefGoogle Scholar
136.Dolberg, OT, Schreiber, S, Grunhaus, L. Transcranial magnetic stimulation-induced switch into mania: a report of two cases. Biol Psychiatry. 2001;49:468–470.CrossRefGoogle Scholar
137.McElroy, SL, Keck, PE Jr.Pharmacologic agents for the treatment of acute bipolar mania. Biol Psychiatry. 2000;48:539–557.CrossRefGoogle ScholarPubMed
138.Cookson, J. Use of antipsychotic drugs and lithium in mania. Br J Psychiatry Suppl. 2O01;41:S148–S156.CrossRefGoogle Scholar
139.Keck, PE Jr, Mendlwicz, J, Calabrese, JR, et al.A review of randomized, controlled clinical trials in acute mania. J Affect Disord. 2000;59(suppl 1):S31–S37.CrossRefGoogle ScholarPubMed
140.Tohen, M, Chengappa, KN, Suppes, T, et al.Efficacy of olanzapine in combination with valproate ot lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry. 2002;59:62–69.CrossRefGoogle ScholarPubMed
141.Sachs, GS, Printz, DJ, Kahn, DA, Carpentet, D, Docherty, JP. The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000. Postgrad Med. 2000;(special issue):1–104.Google Scholar
142.Zarate, CA, Quiroz, JA. Combination treatment in bipolar disorder: a review of controlled trials. Bipolar Disord. 2003;5:217–225.CrossRefGoogle ScholarPubMed
143.Ciapparelli, A, Dell'Osso, L, Tundo, A, et al.Electroconvulsive therapy in medication-nonresponsive patients with mixed mania and bipolar depression. J Clin Psychiatry. 2001;62:552–555.CrossRefGoogle ScholarPubMed
144.Mukherjee, S, Sackeim, HA, Schnur, DB. Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience. Am J Psychiatry. 1994;151:169–176.Google ScholarPubMed
145.Ernst, CL, Goldberg, JF. The reproductive safety profile of mood stabilizers, atypical antipsychotics, and broad-spectrum psychotropics. J Clin Psychiatry. 2002;63 (suppl 4):42–55.Google ScholarPubMed
146.Cohen, LS, Friedman, JM, Jefferson, JW, Johnson, EM, Weiner, ML. A reevaluation of risk of in utero exposure to lithium. JAMA. 1994;271:146–150.CrossRefGoogle ScholarPubMed
147.Lindhout, D, Omtzigt, JG. Pregnancy and the risk of teratogenicity. Epilepsia. 1992;33(suppl 4):S41–S48.CrossRefGoogle ScholarPubMed
148.Kennedy, D, Koren, G. Valproic acid use in psychiatry: issues in treating women of reproductive age. J Psychiatry Neurosci. 1998;23:223–228.Google ScholarPubMed
149.American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics. 2001;108:776–789.CrossRefGoogle Scholar
150.Sajatovic, M. Treatment of bipolar disorder in older adults. Int J Geriotr Psychiatry. 2002;17:865–873.CrossRefGoogle ScholarPubMed
151.Trannel, TJ, Ahmed, I, Goebert, D. Occurrence of thrombocytopenia in psychiatric patients taking valproate. Am J Psychiatry. 2001;158:128–130.CrossRefGoogle ScholarPubMed
152.Tondo, L, Isacsson, G, Baldessarini, R. Suicidal behaviour in bipolar disorder: risk and prevention. CNS Drugs. 2003;17:491–511.CrossRefGoogle ScholarPubMed
153.Dalton, EJ, Cate-Carter, TD, Mundo, E, Parikh, SV, Kennedy, JL. Suicide risk in bipolar patients: the role of co-morbid substance use disorders. Bipolar Disord. 2003;5:58–61.CrossRefGoogle Scholar
154.Baldessarini, RJ, Tondo, L, Hennen, J. Effects of lithium treatment and its discontinuation on suicidal behaviot in bipolar manic-depressive disorders. J Clin Psychiatry. 1999;60(suppl 2):77–84; discussion 111-116.Google Scholar